FDA clenches down on fecal transplants

An effective cure for a brutal bacterial infection is gaining popularity, but there is a price to recognition: the FDA is clamping down on the procedure while researching it as an "investigational new drug." Now that doctors have to do a mountain of paperwork, will it result in a black market for backstreet blendastools?